Immunoglobulin Market, By Product (IgG, IgA, IgM, IgE, and IgD), By Mode of Delivery (Intravenous and Subcutaneous), and By Region, Trends, Analysis and Forecast till 2030

The Immunoglobulin market accounted for USD 9.23 Billion in 2020 and is estimated to be USD 16.62 Billion by 2030 and is anticipated to register a CAGR of 6.1%.

Immunoglobulins are also known as antibodies, which are glycoprotein molecules produced by plasma cells. Immunoglobulin acts as critical part of immune response by specifically recognizing and binding to particular antigens, such as bacteria or viruses. Different classes of immunoglobulin include IgG, IgA, and IgM. Various immunological and neurological diseases can be treated by using these classes of immunoglobulin. This immunoglobulin’s can be administered intravenously and subcutaneously. The increasing application of immunoglobulin is gaining significant traction among pharmaceutical and biopharmaceutical companies for research and development.

Increasing number of product launch

Furthermore, increasing number of product launch and clinical trials for new clinical applications is major factor expected to boost growth of the immunoglobulin market in the near future. Moreover, increasing incidences of primary immunodeficiency disease across the globe is also some among the major drivers for the immunoglobulin market.

The increasing number of geriatric population, which is more prone to develop disease due to low antibody immune response of body, is another factor propelling demand for immunoglobulin. However, stringent regulatory scenario, high cost of treatment, and emergence of alternative therapies is expected hamper growth of the immunoglobulin market in the near future.

immunoglobulin market is segmented on the basis of product, mode of delivery, and geography.

On the basis of product, the immunoglobulin market has been segmented into IgG, IgA, IgM, IgE, and IgD. On the basis of mode of delivery the immunoglobulins market is segmented into intravenous, and subcutaneous. On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.

Regional Insights:

On the basis of region, the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America held the largest share of the market, followed by Europe during the forecast year due to growing aging population and stringent regulations in this region are the major factors driving the growth of the Immunoglobulin industry in North America.

Segments Covered in the Report:

This report forecasts revenue growth at , regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2020 to 2030. For the purpose of this study, has segmented the Immunoglobulin market report based on product, mode of delivery and region.

Global Immunoglobulin Market, By Region:

• North America
  • Middle East & Africa
    • • GCC
      • Israel
      • South Africa
      • Rest of Middle East & Africa
  • Latin America
    • • Brazil
      • Mexico
      • Rest of Latin America
  • Asia Pacific
    • • China
      • India
      • Japan
      • South Korea
      • Rest of Asia Pacific
  • Europe
    • • Germany
      • UK
      • France
      • Russia
      • Italy
      • Rest of Europe
  • U.S.
  • Canada

Key players operating in the immunoglobulin market includes Baxter international Inc., CSL Ltd., Grifols S.A, Octapharma AG, Kedrion Biopharma Inc., LFB group, Biotest AG, China Biologics Products, Inc., BDI Pharma Inc., and Bayer Healthcare.

• Baxter international Inc.
• CSL Ltd.
• Grifols S.A.
• Octapharma AG
• Kedrion Biopharma Inc.
• LFB group
• Biotest AG
• China Biologics Products Inc.
• BDI Pharma Inc.
• Bayer Healthcare